En
Register Log in
  1. Main
  2. Conference
  3. Fundamental and applied research for key propriety...
  4. Immunogistokhimicheskie markery dlia diagnostiki m...

Immunogistokhimicheskie markery dlia diagnostiki melanomy (obzor literatury)

Proceeding
DOI: 10.31483/r-112040
Open Access
All-Russian scientific conference with International Participation «Fundamental and applied research for key propriety areas of bioecology and biotechnology»
Creative commons logo
Published in:
All-Russian scientific conference with International Participation «Fundamental and applied research for key propriety areas of bioecology and biotechnology»
Authors:
Kseniia A. Krasnikova 1 , Atabeg B. Achilov 1 , Elena V. Balatsiuk 1
Work direction:
Клеточная биология, цитология, гистология, анатомия и физиология
Pages:
96-100
Received: 26 May 2024

Rating:
Article accesses:
663
Published in:
РИНЦ
1 Nauchno-issledovatel'skii tsentr fundamental'nykh i prikladnykh problem bioekologii i biotekhnologii FGBOU VO "Ul'ianovskii gosudarstvennyi pedagogicheskii universitet im. I.N. Ul'ianova"
For citation:
Krasnikova K. A., Achilov A. B., & Balatsiuk E. V. (2024). Immunogistokhimicheskie markery dlia diagnostiki melanomy (obzor literatury). Fundamental and applied research for key propriety areas of bioecology and biotechnology, 96-100. Чебоксары: PH "Sreda". https://doi.org/10.31483/r-112040

Abstract

В обзоре приводится анализ диагностических и прогностических биомаркеров меланомы и невусов, которые применяются для дифференциальной диагностики опухоли кожи.

Acknowledgments

Исследования выполнены за счет субсидий из федерального бюджета Министерства просвещения РФ на финансовое обеспечение выполнения государственного задания №073-00037-2302 от 31.07.2023 г (регистрационный номер 1023012300024-4-1.6.4).

References

  1. 1. Вишневская Я.В. Современная гистологическая, иммуногистохимическая и молекулярно-генетическая диагностика меланомы кожи / Я.В. Вишневская, А.М. Строганова, А.И. Сендерович [и др.] // Сибирский онкологический журнал. – 2012. – №4 (52). – С. 74–75. EDN PBSDSJ
  2. 2. Палкина Н.В. Профилирование экспрессии генов в диагностике меланомы: проблемы и перспективы / Н.В. Палкина, Т.Г. Рукша, В.А. Хоржевский [и др.] // Архив патологии. – 2022. – №84 (2). – С. 64–71. DOI 10.17116/patol20228402164. EDN OBUSMX
  3. 3. Dass S.E. Comparison of SOX-10, HMB-45, and Melan-A in Benign Melanocytic Lesions / S.E. Dass, T. Huizenga, M. Farshchian, D.R. Mehregan // Clin Cosmet Investig Dermatol. 2021. №14. P. 1419–1425.
  4. 4. Hessler M. Melanoma Biomarkers and Their Potential Application for In Vivo Diagnostic Imaging Modalities / M. Hessler, E. Jalilian, Q. Xu [et al.] // International Journal of Molecular Sciences. 2020. №21 (24). P. E9583.
  5. 5. Jury C.S. Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma / C.S. Jury, E.J. McAllister, R.M.MacKie // Br J Dermatol. 2000. №143 (2). P. 269–74.
  6. 6. Karabağ S. The importance of p16 and CD117 expression in melanocytic lesions / S. Karabağ, A. Isal Arslan // ADYÜ Sağlık Bilimleri Derg. 2021. №7 (2). P. 113–119.
  7. 7. Knackstedt T. Malignant melanoma: diagnostic and management update / T. Knackstedt, R.W. Knackstedt, R. Couto, B. Gastman // Plast Reconstr Surg. 2018. №142 (2). P. 202–216.
  8. 8. Lam G.T., Prabhakaran S., Sorvina A. et al. Pitfalls in Cutaneous Melanoma Diagnosis and the Need for New Reliable Markers. Mol Diagn Ther 27, 49–60 (2023). https://doi.org/10.1007/s40291-022-00628-9. EDN WARFJJ
  9. 9. Lezcano C. Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors / C. Lezcano, A.A. Jungbluth, K.J. Busam // Am J Surg Pathol. 2020. №44 (7). P. 893–900. DOI 10.1097/PAS.0000000000001492. EDN MCCSZO
  10. 10. Quilaqueo N. Immunohistochemical markers in the differential diagnosis of melanoma and nevus in humans / N. Quilaqueo [et.al.] // Int. J. Morphol. 2021. №39 (5). P. 1509–1515.
  11. 11. Ricci C., Dika E., Ambrosi F., Lambertini M., Veronesi G., Barbara C. Cutaneous Melanomas: A Single Center Experience on the Usage of Immunohistochemistry Applied for the Diagnosis. Int. J. Mol. Sci. 2022. 23. 5911. https://doi.org/10.3390/ijms23115911. EDN MVENUV
  12. 12. Rusu S. Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma / S. Rusu [еt.al.] // Mol Clin Oncol. 2021. №15 (6). P. 270.
  13. 13. Saleem A. Immunohistochemistry in melanocytic lesions: Updates with a practical review for pathologists / A. Saleem, N. Saisindhu, S. Raghavan Shyam // Seminars in Diagnostic.
  14. 14. Schacht V. Basics of Immunohistochemistry / V. Schacht, J.S. Kern // Journal of Investigative Dermatology. 2015. Т. 135. №3. P. 1–4.
  15. 15. Wandler A. Automated quantification of Ki67/MART1 stains may prevent false-negative melanoma diagnoses / A. Wandler, E. Spaun, T. Steiniche, P.S. Nielsen // J Cutan Pathol. 2016. Т. 43. P. 956–962.
  16. 16. Willis B.C. SOX10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes / B.C. Willis, G. Johnson, J. Wang, C. Cohen // Appl Immunohistochem Mol Morphol. 2015. №23 (2). P. 109–12.

Comments(0)

When adding a comment stipulate:
  • the relevance of the published material;
  • general estimation (originality and relevance of the topic, completeness, depth, comprehensiveness of topic disclosure, consistency, coherence, evidence, structural ordering, nature and the accuracy of the examples, illustrative material, the credibility of the conclusions;
  • disadvantages, shortcomings;
  • questions and wishes to author.